Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lipsky

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2009
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypesTodd Lencz, Robert H Lipsky, Pamela DeRosse, et al.
Genetic Testing|December 20, 2002
Determination of melting temperature for variant detection using dHPLC: a comparison between an empirical approach and DNA melting prediction softwareJoseph G Rudolph, Stephanie White, Cara Sokolsky, et al.
Neurotoxicity Research|November 17, 2004
Inhibition of protein kinase C promotes neuronal survival in low potassium through an Akt-dependent pathwayDaming Zhu, Xueying Jiang, Xuan Wu, et al.
Thrombosis and Haemostasis|April 8, 1991
Detection of GPIV (CD36) mRNA in Naka- plateletsR H Lipsky, D A Sobieski, N N Tandon, et al.
Restorative Neurology and Neuroscience|July 24, 2004
Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotypeAnn M Marini, Xueying Jiang, Xuan Wu, et al.
Biomed Research International|March 20, 2015
Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?Nicolas Blondeau, Robert H Lipsky, Miled Bourourou, et al.
Frontiers in Neuroscience|October 25, 2024
Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical managementRobert H Lipsky, Jeffrey M Witkin, Hana Shafique, et al.
Journal of Neurochemistry|July 20, 2001
Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotectionR H Lipsky, K Xu, D Zhu, et al.
British Journal of Pharmacology|October 1, 2009
Differential actions of ethanol and trichloroethanol at sites in the M3 and M4 domains of the NMDA receptor GluN2A (NR2A) subunitA K Salous, H Ren, K A Lamb, et al.
Blood|June 15, 1994
Identification of molecular defects in a subject with type I CD36 deficiencyH Kashiwagi, Y Tomiyama, S Kosugi, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2009
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypesTodd Lencz, Robert H Lipsky, Pamela DeRosse, et al.
Genetic Testing|December 20, 2002
Determination of melting temperature for variant detection using dHPLC: a comparison between an empirical approach and DNA melting prediction softwareJoseph G Rudolph, Stephanie White, Cara Sokolsky, et al.
Neurotoxicity Research|November 17, 2004
Inhibition of protein kinase C promotes neuronal survival in low potassium through an Akt-dependent pathwayDaming Zhu, Xueying Jiang, Xuan Wu, et al.
Thrombosis and Haemostasis|April 8, 1991
Detection of GPIV (CD36) mRNA in Naka- plateletsR H Lipsky, D A Sobieski, N N Tandon, et al.
Restorative Neurology and Neuroscience|July 24, 2004
Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotypeAnn M Marini, Xueying Jiang, Xuan Wu, et al.
Biomed Research International|March 20, 2015
Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?Nicolas Blondeau, Robert H Lipsky, Miled Bourourou, et al.
Frontiers in Neuroscience|October 25, 2024
Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical managementRobert H Lipsky, Jeffrey M Witkin, Hana Shafique, et al.
Journal of Neurochemistry|July 20, 2001
Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotectionR H Lipsky, K Xu, D Zhu, et al.
British Journal of Pharmacology|October 1, 2009
Differential actions of ethanol and trichloroethanol at sites in the M3 and M4 domains of the NMDA receptor GluN2A (NR2A) subunitA K Salous, H Ren, K A Lamb, et al.
Blood|June 15, 1994
Identification of molecular defects in a subject with type I CD36 deficiencyH Kashiwagi, Y Tomiyama, S Kosugi, et al.
Pageof 18